India ' s Reliance Grabs Rights to Biosimilars in Epirus Bankruptcy

Reliance Life Sciences, the biopharmaceutical unit of India-based Reliance Industries, has acquired the global rights for biosimilars of Infliximab.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news